Condition: Acute Coronary Syndrome · Sponsor: Centro Cardiopatici Toscani
Registration of all ACS patients (STEMI and NSTEMI) admitted to the cardiology ward and scheduled for early invasive strategy. The aim is to evaluate the protective effects of early (on admission) high-dose high-potency statin therapy on early and mid-term cardiac and renal events in this subset of patients.
This description comes directly from the study's public registry record.
Anna Toso, MD · 00393387982507 · anna.toso@libero.it
Mario Leoncini, MD · 0039-0574803738 · leoncini.mario@tiscali.it
Always discuss trial participation with your own doctor first.
| Cardiology Division, Prato Hospital | Prato, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04087200